The serotonin syndrome: review of the
literature and description of an
original study
by
Lejoyeux M, Rouillon F, Leon E, Ades J
Service de Psychiatrie,
Groupe hospitalier Bichat-Claude Bernard, Paris.
Encephale 1995 Sep-Oct; 21(5):537-43
ABSTRACT
In animals the occurrence of a behavioural syndrome consisting of
hyperactivity, stereotyped movements and increase of temperature has been
induced by MAOIs, 5-HT precursors (L-tryptophan) and 5-HT reuptake inhibitors.
Most of these manifestations were specifically blocked by a pretreatment with an
inhibitor of serotonin synthesis. In humans, the association of myoclonus,
diarrhea, confusion, hypomania, agitation, hyperreflexia, shivering,
incoordination, fever and diaphoresis, when patients are treated with
serotoninergic agents, could constitute a "serotonin syndrome". Such cases of
serotonin syndrome were reported after treatments with L-tryptophan, MAOIs,
serotonin reuptake inhibitors and tricyclics alone or in association. The
authors prospectively evaluated all the "serotonin-related" symptoms in 38
depressed inpatients fulfilling DSM III-R criteria of major depression. 16 (42%)
out of 38 patients presented at least one symptom of serotonin syndrome. In 14
cases tremor and myoclonus occurred simultaneously and 10 patients presented at
the same time tremor, myoclonus, diaphoresis and shivering. Except for two
patients, symptoms were transient, lasted less than one week and disappeared
with the pursuit of the treatment. Most often, serotonin syndrome thus
corresponds to a reaction induced by a combination of serotoninergic agents at
high dosages. In very rare cases, a toxic and potentially fatal interaction can
occur between MAOIs, tricyclics and selective serotonin reuptake inhibitors at
therapeutic dosages. Serotonin syndrome also provides an heuristic model of the
putative mode of action of antidepressants. Serotonin-related symptoms are the
physical and objective expression of the antidepressant-induced increase in
serotonin. The specificity of serotonin-related syndrome also needs to be
discussed since most of the symptoms, such as tremor and diaphoresis, are not in
all cases related to an increase in serotonin.
TCAs
SSRIs
MAOIs
MDMA
Serotonin
Phenelzine
Tryptophan
Isocarboxazid
The MAOI Diet
MTA and MMAI
Tranylcypromine
Methylphenidate
The serotonin syndrome
The serotonin syndrome and opioids
Antidepressants and the serotonin syndrome
Risperdone (Risperdal) for the serotonin syndrome
Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family